Revvity, Inc. (RVTY)

Market Cap	14.41B
Revenue (ttm)	2.72B
Net Income (ttm)	254.30M
Shares Out	121.70M
EPS (ttm)	2.06
PE Ratio	56.58
Forward PE	23.82
Dividend	$0.28 (0.24%)
Ex-Dividend Date	Jan 17, 2025

Volume	659,307
Open	119.32
Previous Close	119.46
Day's Range	118.23 - 120.36
52-Week Range	97.32 - 129.50
Beta	1.03
Analysts	Buy
Price Target	132.85 (+12.21%)
Earnings Date	Jan 31, 2025

About RVTY

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its pro...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1937
• Employees: 11,500
• Stock Exchange: NYSE
• Ticker Symbol: RVTY
• Website: https://www.revvity.com

Financial Performance

In 2023, Revvity's revenue was $2.75 billion, a decrease of -16.95% compared to the previous year's $3.31 billion. Earnings were $693.09 million, an increase of 21.77%.

Analyst Forecast

According to 13 analysts, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $132.85, which is an increase of 12.21% from the latest price.

Price Target

$132.85

(12.21% upside)

Analyst Consensus: Buy